MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1
Endocrine · 01.04.2026 · 91 (1)
DOI: 10.1007/s12020-025-04495-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 01.04.2026. Verfasst von Ying Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China. Hauptthemen laut MEDLINE: MicroRNAs, Forkhead Transcription Factors, Thyroid Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China.
- Department of Pathology, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
- Department of Pathology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China. reazon@vip.163.com.
Zitieren
APA
Li, Y., Chen, W., Zhang, L., Zeng, Y., Wang, Y., Zhang, Y. L., Li, L., & Shi, H. (2026). MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1. Endocrine, 91(1). https://doi.org/10.1007/s12020-025-04495-2
Vancouver
Li Y, Chen W, Zhang L, Zeng Y, Wang Y, Zhang YL, et al. MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1. Endocrine. 2026;91(1). doi:10.1007/s12020-025-04495-2
BibTeX
@article{Li2026,
author = {Li, Ying and Chen, Wei and Zhang, Ling and Zeng, Yan and Wang, Yun and Zhang, Yan-Li and Li, Li and Shi, Huaiyin},
title = {MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1},
journal = {Endocrine},
year = {2026},
volume = {91},
number = {1},
doi = {10.1007/s12020-025-04495-2}
}
EUVIMED